GDF Pharmaceuticals Private Limited
About GDF Pharmaceuticals Private Limited
Data last updated:
GDF Pharmaceuticals Private Limited is a private limited company based in Gorakhpur, Uttar Pradesh, India. It operates in the wholesale trading and distribution segment of the business services sector. It was incorporated on 28 December 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U51101UP2015PTC075315. Its GSTIN is 09AAGCG5125M1ZB (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Praveen Kumar Singh and Girish Kumar Singh.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shakti Nagar West 136/E Gorakhpur, Uttar Pradesh, India – 273016.
As per the financials filed for FY 2025, the company reported a revenue of ₹88.68 Lakh, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹1.33 Lakh (net margin 1.5%) and EBITDA of ₹1.82 Lakh (EBITDA margin 2.1%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years and 17% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShakti Nagar West 136/E Gorakhpur, Uttar Pradesh, India – 273016
- IndustryBusiness Services, Wholesale, Live Animal, Contractual Work, Commission Agents Dealing In Agricultural Raw Material
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of GDF Pharmaceuticals Private Limited
The main business activity of GDF Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of GDF Pharmaceuticals Private Limited FY 2025 filings available
GDF Pharmaceuticals Private Limited reported revenue of ₹88.68 Lakh (up 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of GDF Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 17% over five years, including 11% growth in the latest year. EBITDA rose 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of GDF Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.82 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.33 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of GDF Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of GDF Pharmaceuticals are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of GDF Pharmaceuticals Private Limited
GDF Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Glamatic Pharmaceuticals Private Limited | ₹89.16 Lakh (FY 2022) | •••• | •••• | •••• | Kolkata, West Bengal, India | |
| Addyama Pharmaceuticals Private Limited | ₹89.11 Lakh (FY 2024) | •••• | •••• | -4.0% | •••• | Kolkata, West Bengal, India |
| Claribel Pharmaceuticals Private Limited | ₹88.92 Lakh (FY 2025) | •••• | •••• | 29.0% | •••• | Hyderabad, Telangana, India |
| Cell Cross Pharmaceuticals Private Limited | ₹88.89 Lakh (FY 2025) | •••• | •••• | 54.0% | •••• | Kangra, Himachal Pradesh, India |
| Sightom Pharmaceuticals Private Limited | ₹88.81 Lakh (FY 2024) | •••• | •••• | 15.0% | •••• | New Delhi, Delhi, India |
| GDF Pharmaceuticals Private Limited this company | ₹88.68 Lakh (FY 2025) | •••• | •••• | 11.0% | •••• | Gorakhpur, Uttar Pradesh, India |
| Vrisan Pharmaceuticals Private Limited | ₹88.49 Lakh (FY 2024) | •••• | •••• | 146.0% | •••• | Ward-Fazullaganj, Uttar Pradesh, India |
| Nuclomed Pharmaceuticals Private Limited | ₹88.43 Lakh (FY 2024) | •••• | •••• | -3.0% | •••• | Moradabad, Uttar Pradesh, India |
| Tossvet Pharmaceuticals India Private Limited | ₹88.36 Lakh (FY 2024) | •••• | •••• | •••• | Solapur, Maharashtra, India | |
| Lecuris Pharmaceuticals Private Limited | ₹88.21 Lakh (FY 2025) | •••• | •••• | 17.0% | •••• | Kolhapur, Maharashtra, India |
| Bionav Pharmaceuticals (OPC) Private Limited | ₹88.11 Lakh (FY 2025) | •••• | •••• | -39.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below GDF Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of GDF Pharmaceuticals Private Limited
GDF Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Praveen Kumar Singh | Director | 28 Dec 2015 | 10 Years 9 Months | Current |
| Girish Kumar Singh | Director | 28 Dec 2015 | 10 Years 9 Months | Current |
Ownership and Shareholding of GDF Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of GDF Pharmaceuticals Private Limited
GDF Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at GDF Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to GDF Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on GDF Pharmaceuticals Private Limited
GDF Pharmaceuticals Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Girish Kumar Singh was appointed as Director on 28 Dec 2015.
Credit Ratings, Litigation & Regulatory Alerts for GDF Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by GDF Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of GDF Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of GDF Pharmaceuticals Private Limited
GDF Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCG5125M1ZB | Uttar Pradesh | Active | 01 May 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of GDF Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GDF Pharmaceuticals Private Limited
GDF Pharmaceuticals is an active private limited company based in Gorakhpur, Uttar Pradesh, India. The company works in wholesale, within the business services industry. It was incorporated on 28 December 2015 (11+ years old) and is registered under CIN U51101UP2015PTC075315.
GDF Pharmaceuticals reported revenue of ₹88.68 Lakh for FY 2025 (up 11% YoY).
GDF Pharmaceuticals has 2 current directors:
- Praveen Kumar Singh - Director
- Girish Kumar Singh - Director
GDF Pharmaceuticals reported a net profit of ₹1.33 Lakh (net margin 1.5%) and EBITDA of ₹1.82 Lakh (EBITDA margin 2.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of GDF Pharmaceuticals is 15% over three years and 17% over five years. In the latest year (FY 2025) revenue rose 11%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of GDF Pharmaceuticals is 09AAGCG5125M1ZB, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of GDF Pharmaceuticals is U51101UP2015PTC075315. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
GDF Pharmaceuticals was incorporated on 28 December 2015, making it 11+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of GDF Pharmaceuticals by revenue are Glamatic Pharmaceuticals Private Limited, Addyama Pharmaceuticals Private Limited, Claribel Pharmaceuticals Private Limited, Cell Cross Pharmaceuticals Private Limited, Sightom Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Girish Kumar Singh was appointed as Director on 28 Dec 2015. Praveen Kumar Singh was appointed as Director on 28 Dec 2015.
The registered office of GDF Pharmaceuticals is at Shakti Nagar West 136E Gorakhpur, Uttar Pradesh, India – 273016.